Antonio Penna
Overview
Explore the profile of Antonio Penna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
231
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tursi A, Procaccianti G, De Bastiani R, Turroni S, DAmico F, Allegretta L, et al.
Front Med (Lausanne)
. 2025 Mar;
12:1487892.
PMID: 40078388
The role of gut microbiota (GM) in the pathogenesis of Symptomatic Uncomplicated Diverticular Disease (SUDD) remains controversial. Here, we assessed the efficacy of a butyrate formulation in modulating GM and...
2.
Tursi A, Turroni S, De Bastiani R, Procaccianti G, DAmico F, Allegretta L, et al.
Eur J Gastroenterol Hepatol
. 2024 Nov;
37(2):147-153.
PMID: 39514266
Objective: Patients with symptomatic uncomplicated diverticular disease (SUDD) may have a disrupted gut microbiota. However, current data are from small sample studies, and reported associations vary widely across studies. We...
3.
Willcox D, Trent R, Lyons N, Meldrum C, Kennedy P, Lee T, et al.
Aust Health Rev
. 2023 Oct;
47(6):631-633.
PMID: 37844625
NSW Health is implementing genomics as a mainstream component of clinical care. The strategic, holistic approach is considering infrastructure, data governance and management, workforce, education, service planning and delivery. This...
4.
Mocci G, Tursi A, Maconi G, Cataletti G, Mantia B, Serio M, et al.
Expert Opin Biol Ther
. 2023 Feb;
23(3):293-304.
PMID: 36843568
Background: Vedolizumab (VDZ) can be used to treat refractory ulcerative colitis (UC) and Crohn's disease (CD). We assessed whether there are differences in treating UC vs CD with VDZ. Research...
5.
Tursi A, Mocci G, Cuomo A, Ferronato A, Elisei W, Picchio M, et al.
J Gastrointestin Liver Dis
. 2022 Dec;
31(4):411-416.
PMID: 36535057
Background And Aims: Adalimumab (ADA) biosimilars have been included into the therapeutic armamentarium of inflammatory bowel disease (IBD); however, comparative data on the efficacy and safety of the different ADA...
6.
Tursi A, Mocci G, Allegretta L, Aragona G, Bianco M, Colucci R, et al.
Inflamm Bowel Dis
. 2022 May;
29(3):376-383.
PMID: 35579320
Background: Adalimumab (ADA) biosimilars have entered the therapeutic armamentarium of inflammatory bowel disease (IBD), allowing for the treatment of a greater number of patients for their reduced cost than the...
7.
Tursi A, Mocci G, Allegretta L, Aragona G, Bianco M, Colucci R, et al.
Expert Opin Biol Ther
. 2021 Dec;
22(2):313-320.
PMID: 34904510
Background: To compare the performances of Infliximab (IFX) biosimilar CT-P13 and SB2 in the treatment of Inflammatory Bowel Diseases (IBD) outpatients in Italy. Research Design And Methods: Three hundred and...
8.
Tursi A, Mocci G, Elisei W, Allegretta L, Colucci R, Della Valle N, et al.
J Gastrointestin Liver Dis
. 2021 Nov;
30(4):456-461.
PMID: 34812437
Background And Aims: Several studies have found Golimumab (GOL) effective and safe in the short-term treatment of ulcerative colitis (UC), but few long-term data are currently available from real world....
9.
Campbell D, Edwards B, Milat A, Thackway S, Whittaker E, Goudswaard L, et al.
Public Health Res Pract
. 2021 Nov;
31(4).
PMID: 34753169
Objectives: The NSW Health COVID-19 Research Program was established in April 2020 to contribute to minimising the health, social and economic impacts of the coronavirus disease 2019 (COVID-19) pandemic in...
10.
Tursi A, Picchio M, Elisei W, Allegretta L, Benedicenti P, Bossa F, et al.
Rev Recent Clin Trials
. 2021 Jun;
16(3):329-334.
PMID: 34126909
Background: Although FD may affect up to 10% of the general population, the therapy for FD is not standard. Recently, ginger-based food supplements have been proposed in order to restore...